GlobeNewsWire
26 Aug 2026, 02:34 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
3 claims · each scored for market impact
PROCEPT BioRobotics experienced a cumulative excess field inventory of over 10,000 handpiece units due to sales materially exceeding actual procedures. — Significant inventory gluts indicate inflated revenue figures and poor demand forecasting, suggesting fundamental operational issues.
-0.80The company missed its annual revenue guidance by tens of millions of dollars following a nearly 30% sequential decline in U.S. handpiece unit sales. — Large revenue misses and sharp declines in unit sales directly impact valuation and investor confidence in growth projections.
-0.70A securities class action lawsuit has been filed against PROCEPT BioRobotics alleging the company failed to disclose material inventory issues between February 2024 and February 2026. — Legal proceedings for securities fraud create additional financial liability and reputational risk for the company.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
